PTX 2.56% 3.8¢ prescient therapeutics limited

Ann: Edison Investment Research Initiates Coverage, page-2

  1. 22,120 Posts.
    lightbulb Created with Sketch. 20
    We all knew PTX was cheap but good to have external confirmation of this

    Valuation:A$35m or A$0.66 per share
    We value Prescient at A$35m or A$0.66 per share, compared to its market capitalisation of A$4m
    . Taking into account 14m potential deferred acquisition shares and 6.4m options we calculate a diluted value of A$0.48 per share (this does not account for any dilution from additional~A$6m funding we estimate may
    be required in FY16).

    They need to take a lead from NRT and go to the US Instos for funding
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $30.60M
Open High Low Value Volume
3.9¢ 3.9¢ 3.8¢ $47.91K 1.256M

Buyers (Bids)

No. Vol. Price($)
11 881755 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 150000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.